Inventor · disambiguated record
Hao Wang
Also filed as: WANG HAO · WANG HAO-LIAN
2 granted patents·22 pending applications·4 citations·filing 2001–2025
42Inventor score
Files withALEXION PHARMA INC4ARGOS THERAPEUTICS INC2GUARDANT HEALTH INC2SH NAT ENG RES CT NANOTECH CO2ABBADIE CATHERINE1
Top patents by PatentIndex Score
24 records- 0174US9447187B2Use of an anti-CD200 antibody for prolonging the survival of allograftsWANG YI·Filed 2012·Granted Sep 20, 2016·4 cites·23 claims
- 0274US2023158109A1Use of cd83 in combination therapiesCOLMMUNE INC·Filed 2022·Application pending·0 cites
- 0371US2025069687A1Characterization of whole genome duplication in a genomic cohort of over 14000 cell free dna samplesGUARDANT HEALTH INC·Filed 2024·Application pending·0 cites
- 0468US2014010821A1Use of CD83 in combination therapiesLAO AILI·Filed 2007·Application pending·0 cites
- 0562US2024336917A1Compositions and methods for inhibiting the expression of tmigd2ALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0659US2016324926A1Use of CD83 in Combination TherapiesARGOS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 0759US2016008440A1Use of CD83 in Combination TherapiesARGOS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 0857US2022344004A1Detecting the presence of a tumor based on off-target polynucleotide sequencing dataGUARDANT HEALTH INC·Filed 2022·Application pending·0 cites
- 0957US2019309053A1Prolongation of survival of an allograft by inhibiting complement activityALEXION PHARMA INC·Filed 2018·Application pending·0 cites
- 1054US2009028850A1Prolongation of survival of an allograft by inhibiting complement activityALEXION PHARMA INC·Filed 2005·Application pending·0 cites
- 1154US2006205761A1Ccr-2 antagonists for treatment of neuropathic painABBADIE CATHERINE·Filed 2004·Application pending·0 cites
- 1252US2017267751A1Prolongation of survival of an allograft by inhibiting complement activityALEXION PHARMA INC·Filed 2017·Application pending·0 cites
- 1351US2025188173A1Method of Treating an Eosinophil-Associated DiseaseCSL Innovation Pty Ltd·Filed 2023·Application pending·0 cites
- 1451US2024119314A1Gene coding breeding prediction method and device based on graph clusteringZhejiang Lab·Filed 2023·Application pending·0 cites
- 1549US2024217921A1Cinnamoyl amino acid compound and use thereofUNIV CHINA PHARMA·Filed 2020·Application pending·0 cites
- 1646US2010135992A1Prolongation of Survival of an Allograft by Inhibiting Complement ActivityALEXION PHARMA INC·Filed 2007·Application pending·0 cites
- 1744US2024150742A1Gene for efficiently expressing hyaluronic acid hydrolase and expression method thereofBLOOMAGE BIOTECHNOLOGY CORP LTD·Filed 2021·Application pending·0 cites
- 1844US2004106773A1Human tuberoinfundibular peptide of 39 residuesFiled 2001·Application pending·0 cites
- 1943US2025375417A1Orexin receptor 2 (ox2r) agonist for use in narcolepsy type 1 (nt1)TAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 2041US2010311955A1Humanized anti-human cd34 antibody, the preparation method and uses thereofSHANHAI GUOJIAN BIO TECH INST·Filed 2008·Application pending·0 cites
- 2140US2010151486A1Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereofSH NAT ENG RES CT NANOTECH CO·Filed 2008·Application pending·0 cites
- 2240US2025309069A1Packaged chipREALTEK SEMICONDUCTOR CORP·Filed 2025·Application pending·0 cites
- 2338US12383573B2Use of luteolin-7-O-glucoside or luteolin-7-O-glucuronide in preparation of medicine for eye injuriesBEIJING CHENGYI INVEST CO LTD·Filed 2019·Granted Aug 12, 2025·0 cites·6 claims
- 2438US2010239588A1The functional epitope of osteopontin, the anti-osteopontin monoclonal antibody and use thereofSH NAT ENG RES CT NANOTECH CO·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hao Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →